Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.

Hargreaves PG, Al-Shamkhani A.

Eur J Immunol. 2002 Jan;32(1):163-73.

2.

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.

Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA.

J Immunol. 2004 Sep 1;173(5):2933-41.

3.

Expression of CD30 ligand (CD153) on murine activated T cells.

Shimozato O, Takeda K, Yagita H, Okumura K.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):519-26.

PMID:
10080930
4.

Construction and expression of a soluble form of human CD30 ligand with functional activity.

Powell IF, Li T, Jäck HM, Ellis TM.

J Leukoc Biol. 1998 Jun;63(6):752-7.

PMID:
9620669
5.

Reverse signaling via CD30 ligand.

Wiley SR, Goodwin RG, Smith CA.

J Immunol. 1996 Oct 15;157(8):3635-9.

PMID:
8871664
7.

Structure and expression of murine CD30 and its role in cytokine production.

Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER.

J Immunol. 1996 Jan 15;156(2):442-9.

PMID:
8543792
8.

Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.

Pera MF, Bennett W, Cerretti DP.

Lab Invest. 1997 Apr;76(4):497-504.

PMID:
9111512
9.

CD153 in rheumatoid arthritis: detection of a soluble form in serum and synovial fluid, and expression by mast cells in the rheumatic synovium.

Carvalho RF, Ulfgren AK, Engström M, Klint Ea, Nilsson G.

J Rheumatol. 2009 Mar;36(3):501-7. doi: 10.3899/jrheum.080288. Epub 2009 Jan 22.

PMID:
19208589
10.

Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro.

Matsumoto K, Terakawa M, Miura K, Fukuda S, Nakajima T, Saito H.

J Immunol. 2004 Feb 15;172(4):2186-93.

11.

Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.

Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, Harvima IT.

Cancer Immunol Immunother. 2007 Sep;56(9):1407-15. Epub 2007 Feb 1.

PMID:
17268792
12.

A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.

Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, Podack ER, Yoshikai Y.

J Immunol. 2008 Nov 1;181(9):6316-27.

13.

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.

Wajant H, Moosmayer D, Wüest T, Bartke T, Gerlach E, Schönherr U, Peters N, Scheurich P, Pfizenmaier K.

Oncogene. 2001 Jul 5;20(30):4101-6.

14.

Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.

Flórido M, Borges M, Yagita H, Appelberg R.

J Leukoc Biol. 2004 Nov;76(5):1039-46. Epub 2004 Aug 17.

PMID:
15316035
15.

A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells.

Nishimura H, Yajima T, Muta H, Podack ER, Tani K, Yoshikai Y.

J Immunol. 2005 Oct 1;175(7):4627-34.

16.

Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.

Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hübinger G, Kieff E, Herrmann F, Leutz A, Gruss HJ.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14053-8. Retraction in: Kieff E. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12732.

17.

CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.

Gattei V, Degan M, Gloghini A, De Iuliis A, Improta S, Rossi FM, Aldinucci D, Perin V, Serraino D, Babare R, Zagonel V, Gruss HJ, Carbone A, Pinto A.

Blood. 1997 Mar 15;89(6):2048-59.

18.

Direct evidence for a critical role of CD30 in the development of allergic asthma.

Polte T, Behrendt AK, Hansen G.

J Allergy Clin Immunol. 2006 Oct;118(4):942-8. Epub 2006 Sep 6.

PMID:
17030250
19.

Role for CD30 in HIV expression.

Romagnani S, Annunziato F, Manetti R, Almerigogna F, Biagiotti R, Giudizi MG, Ravina A, Giannò V, Tomasévic L, Maggi E.

Immunol Lett. 1996 Jun;51(1-2):83-8.

PMID:
8811349
20.

CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.

Telford WG, Nam SY, Podack ER, Miller RA.

Cell Immunol. 1997 Dec 15;182(2):125-36.

PMID:
9514701

Supplemental Content

Support Center